Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts

[1]  C. Newgard,et al.  Branched-chain amino acids in disease , 2019, Science.

[2]  C. Gieger,et al.  Circulating metabolic biomarkers of renal function in diabetic and non-diabetic populations , 2018, Scientific Reports.

[3]  J. Viikari,et al.  Effect of Dietary Counseling on a Comprehensive Metabolic Profile from Childhood to Adulthood , 2018, The Journal of pediatrics.

[4]  D. Mozaffarian,et al.  Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies. , 2017, The lancet. Diabetes & endocrinology.

[5]  G. Davey Smith,et al.  Genetic Support for a Causal Role of Insulin Resistance on Circulating Branched-Chain Amino Acids and Inflammation , 2017, Diabetes Care.

[6]  Tom R. Gaunt,et al.  PhenoSpD: an integrated toolkit for phenotypic correlation estimation and multiple testing correction using GWAS summary statistics , 2017, bioRxiv.

[7]  Debbie A Lawlor,et al.  Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies , 2017, American journal of epidemiology.

[8]  T. Greenhalgh,et al.  Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions , 2017, British Medical Journal.

[9]  D. Lawlor,et al.  Metabolic profiling of pregnancy: cross-sectional and longitudinal evidence , 2016, BMC Medicine.

[10]  Inês Barroso,et al.  Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis , 2016, PLoS medicine.

[11]  T. Lehtimäki,et al.  Role of Conventional Childhood Risk Factors Versus Genetic Risk in the Development of Type 2 Diabetes and Impaired Fasting Glucose in Adulthood: The Cardiovascular Risk in Young Finns Study , 2016, Diabetes Care.

[12]  Frank B Hu,et al.  Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis , 2016, Diabetes Care.

[13]  M. M. Rahman,et al.  Worldwide trends in diabetes since 1980 : pooled analysis of 751 population-based measurement studies with over 4 . 4 million participants , 2016 .

[14]  J. Rabinowitz,et al.  A branched chain amino acid metabolite drives vascular transport of fat and causes insulin resistance , 2016, Nature Medicine.

[15]  Ming-Huei Chen,et al.  Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes , 2016, PloS one.

[16]  Liam G. Fearnley,et al.  The Biomarker GlycA Is Associated with Chronic Inflammation and Predicts Long-Term Risk of Severe Infection. , 2015, Cell systems.

[17]  Daniel F. Freitag,et al.  Association of Cardiometabolic Multimorbidity With Mortality. , 2015, JAMA.

[18]  M. Laakso,et al.  Associations of multiple lipoprotein and apolipoprotein measures with worsening of glycemia and incident type 2 diabetes in 6607 non-diabetic Finnish men. , 2015, Atherosclerosis.

[19]  M. Connelly,et al.  GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation. , 2015, Clinical chemistry.

[20]  Tom R. Gaunt,et al.  Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. , 2015, Circulation.

[21]  B. Vergès.  Pathophysiology of diabetic dyslipidaemia: where are we? , 2015, Diabetologia.

[22]  Sophie V. Eastwood,et al.  Diabetes risk and amino acid profiles: cross-sectional and prospective analyses of ethnicity, amino acids and diabetes in a South Asian and European cohort from the SABRE (Southall And Brent REvisited) Study , 2015, Diabetologia.

[23]  Pasi Soininen,et al.  Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. , 2015, Circulation. Cardiovascular genetics.

[24]  Samuli Ripatti,et al.  Metabolic Signatures of Adiposity in Young Adults: Mendelian Randomization Analysis and Effects of Weight Change , 2014, PLoS medicine.

[25]  Christian Gieger,et al.  Biomarkers for Type 2 Diabetes and Impaired Fasting Glucose Using a Nontargeted Metabolomics Approach , 2013, Diabetes.

[26]  M. Laakso,et al.  Glycerol and Fatty Acids in Serum Predict the Development of Hyperglycemia and Type 2 Diabetes in Finnish Men , 2013, Diabetes Care.

[27]  Thomas J. Wang,et al.  A diabetes-predictive amino acid score and future cardiovascular disease. , 2013, European heart journal.

[28]  Bryan C. Batch,et al.  Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness. , 2013, Metabolism: clinical and experimental.

[29]  A. Peters,et al.  Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach , 2013, Diabetes.

[30]  S. Aunola,et al.  Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS) , 2013, Diabetologia.

[31]  M. Laakso,et al.  Lipoprotein subclass profiles in individuals with varying degrees of glucose tolerance: a population‐based study of 9399 Finnish men , 2012, Journal of Internal Medicine.

[32]  Jussi Paananen,et al.  Hyperglycemia and a Common Variant of GCKR Are Associated With the Levels of Eight Amino Acids in 9,369 Finnish Men , 2012, Diabetes.

[33]  Tuija Tammelin,et al.  Metabolic Signatures of Insulin Resistance in 7,098 Young Adults , 2012, Diabetes.

[34]  C. Newgard.  Interplay between lipids and branched-chain amino acids in development of insulin resistance. , 2012, Cell metabolism.

[35]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[36]  Vilmundur Gudnason,et al.  Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death , 2011 .

[37]  Ewout W Steyerberg,et al.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers , 2011, Statistics in medicine.

[38]  V. Salomaa,et al.  Thirty-One Novel Biomarkers as Predictors for Clinically Incident Diabetes , 2010, PloS one.

[39]  P. Ridker,et al.  Lipoprotein Particle Size and Concentration by Nuclear Magnetic Resonance and Incident Type 2 Diabetes in Women , 2010, Diabetes.

[40]  Mika Kivimäki,et al.  Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study , 2009, The Lancet.

[41]  J. Lindström,et al.  Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study , 2006, The Lancet.

[42]  H. Campos,et al.  The use of fatty acid biomarkers to reflect dietary intake , 2006, Current opinion in lipidology.

[43]  조남욱.  전자/제조업의 Collaboration 전략 , 2003 .

[44]  N. Golden,et al.  in Women with , 1992 .